Entering Taiwan’s Cosmetics Market: Importer Selection, Product Registration, PIF Preparation and Retention, and Advertising Rules

A foreign cosmetics brand seeking to distribute products in Taiwan must decide who will handle importation, when product registration will be completed, who will manage the Product Information File (PIF) and where it will be retained, and how labeling and advertising will be reviewed. Korean brands may either use a local importer or operate directly in Taiwan, so forming a company alone does not complete the preparations required for sale.

The applicable obligations may vary according to the product type and manufacturing site, the actual import structure, the distribution method, and the content of the advertising. This article distinguishes among the market-entry structure and the entity bearing statutory responsibility, TFDA product registration, PIF preparation, updating, and retention, labeling and advertising, and inspections and corrective measures. Before setting an actual supply schedule, the latest laws and guidance from the competent authorities should be rechecked for each product.

1. Choosing a Taiwan Market-Entry Structure and Importer

No. A Taiwan importer—including one that also serves as the distributor—may handle importation and sales. If the brand operates directly in Taiwan, a Taiwan subsidiary and a Taiwan branch of a foreign company differ in their formation and registration, liability, and tax structures. The time required for foreign-investment approval and company or branch registration also varies according to the particular matter and whether supplemental documents are requested. The brand should first choose its business model and identify the entity that will assume the legal responsibilities of the cosmetics manufacturer or importer.

Using a Taiwan Importer

If a Taiwan importer or distributor handles importation and sales, a foreign brand may operate without its own Taiwan subsidiary or branch. The distributor may also serve as the importer, or a separate importer may participate. Contractual labels such as agent, master distributor, or distributor do not by themselves determine where legal responsibility lies.

When allocating the actual work, the parties should first determine who will import the products and complete product registration, and who will prepare, update, and retain the PIF. They must also designate who will review labeling, maintain distribution records, receive consumer complaints and safety information, and respond to inspections and requests for information from the competent authorities. The statutory obligations imposed on the cosmetics manufacturer or importer should be reviewed together with the contractual tasks allocated between the brand and its sales partner.

The agreement should specify the permitted use of intellectual property such as trademarks and images, and how the manufacturer’s records needed for product registration and the PIF will be provided, translated, and supplemented. It may also cover management of updated records and their handover when the agreement ends, authority to review and revise advertising in advance, transmission of safety information such as complaints and adverse events, cooperation with any necessary recall, and responsibility for testing, translation, and retention costs. To prevent records from remaining solely with one party, the scope and deadline for returning them or providing copies should also be agreed in advance.

Operating Directly in Taiwan

A Taiwan subsidiary and a Taiwan branch of a foreign company are not the same organizational form. A subsidiary is a separate legal entity incorporated under Taiwan law, whereas a branch is registered as part of the foreign company’s head office. Because they differ in legal personality, the head office’s liability, accounting and tax treatment, profit remittance, representative authority, and internal controls, the organizational form should not be selected based solely on the desired degree of sales control.

If foreign-investment procedures are required, the current guidance of the Department of Investment Review, Ministry of Economic Affairs (MOEA) should be consulted. The time needed to obtain investment approval, remit funds, register a company or branch, open a bank account, complete tax registration, and obtain importer status varies according to the investor, industry, organizational form, submitted documents, and whether supplemental documents are requested. Rather than setting a launch date on the assumption of a fixed period, the parties should first confirm which procedures apply and the latest filing requirements.

Whichever structure is chosen, the central responsible entity under cosmetics regulation is the cosmetics manufacturer or importer. Product documentation or the safety assessment may be assigned to an outside expert, but outsourcing alone does not transfer the cosmetics manufacturer’s or importer’s legal responsibility. Distinguishing contractual task allocation from the responsible entity under the law is the starting point for reviewing the market-entry structure.

2. Product Registration and the PIF Are Separate Requirements

No. Product registration is a separate procedure conducted through TFDA’s cosmetics product registration platform. A Product Information File (PIF) compiles information on a cosmetic product’s quality, safety, composition, claimed functions, manufacturing methods, test results, and safety assessment, and must be prepared, updated, and retained by the cosmetics manufacturer or importer. The PIF itself is not submitted to TFDA in advance. From July 1, 2026, the PIF requirements apply in principle to all cosmetics, except solid handmade soap manufactured at a site exempt from factory registration.

When Product Registration Is Required and How Long It Remains Valid

Cosmetic product registration is conducted through TFDA’s cosmetics product registration platform. The cosmetics manufacturer or importer must complete product registration before supplying, selling, giving away, or publicly displaying the product, or providing it to consumers for trial use. Preparations should not focus only on paid sales; the registration timeline must also account for promotional giveaways and consumer trials.

Product registration is valid for three years. To continue supplying the product, an extension must be applied for within the three months before the registration expires. If registered information such as the product name, purpose, dosage form, ingredients, or manufacturing site changes, the business should also determine what procedure is required for the particular change.

Product registration is a procedure for reporting the prescribed registration information through the platform. Completion of registration does not mean that all records required for the PIF are in place, nor does it establish that the product’s labeling or advertising is lawful. Product registration, PIF management, and labeling and advertising review should be operated as separate compliance workstreams.

What the PIF Contains and When the Rules Apply

A PIF is a collection of records designed to provide an ongoing account of a product’s quality and safety. In addition to quality, safety, composition, claimed functions, manufacturing methods, test results, and the safety assessment, supporting records such as basic information about the product and manufacturer and the label must be organized for each product. The Regulations for Cosmetic Product Information File Management organize the required records into 16 categories, so the records and signature and qualification requirements for each category must be checked according to the product type.

The PIF requirements have been implemented in phases by product category. From July 1, 2026, the remaining cosmetics are also covered, so the requirements apply in principle to all cosmetics. The exception is limited to solid handmade soap manufactured at a site exempt from factory registration. A product is not exempt merely because it is handmade or called soap; both its solid form and the manufacturing site’s exemption from factory registration must be confirmed.

A third party with the necessary qualifications and capabilities may assist with PIF work, including the safety assessment. Even when a third party helps prepare or retain the records, however, the cosmetics manufacturer’s or importer’s legal responsibility remains in place. The original manufacturer, testing laboratory, safety assessor, and Taiwan business should establish a system for sharing changed information and current signed records.

Updating and Retaining the PIF

If an ingredient or formula, a manufacturing method or site, labeling including the label, a claimed function, or safety information changes, the affected PIF records must be reviewed and updated. Because consumer complaints, adverse events, and new test results may also affect the existing assessment, a change-control process is required even after the PIF is first prepared.

Under Article 7 of the Regulations for Cosmetic Product Information File Management, the PIF must be retained for at least five years beginning on the day after the product was last supplied to the market. Under Article 8 of the same Regulations, the retention location must be the address of the cosmetics manufacturer or importer specified in Article 7(1)(7) of the Cosmetic Hygiene and Safety Act. The provision governing the retention period and the provision governing the retention location should be distinguished in practice.

Even if the original manufacturer holds the originals or a secure electronic or cloud repository is used, the cosmetics manufacturer or importer must be able to access the complete records. Access rights, backups, version control, file formats, and responsible personnel should be established so that the records can be promptly retrieved and produced at the competent authority’s request. The agreement should also address which records will be handed over, how the handover will occur, and whether access rights will survive so that the records remain available for the statutory retention period after an agreement with a sales partner or service provider ends.

Inspections, Corrective Orders, and Administrative Penalties

When the competent authority inspects a PIF, it must in principle notify the cosmetics manufacturer or importer at least seven days before the inspection. An inspection may, however, be conducted without advance notice if a statutory exception under the applicable regulations applies. Complete and current records should always be maintained in a condition that permits their retrieval and production, regardless of whether notice is given.

Reporting false information in a product registration or recording false information in a PIF may result in an administrative fine of NT$10,000–NT$1,000,000. In contrast, if PIF records are incomplete, the competent authority ordinarily orders correction within a specified period, and an administrative fine may be imposed if the deficiency is not corrected within that period. False information and a remediable documentation deficiency should not be treated as producing the same consequence.

Recall or destruction does not automatically follow every deficiency in PIF documentation. The product’s safety, the nature of the violation, the status of corrective action, and the statutory requirements applicable to each measure must be considered separately. Measures taken when a safety issue is identified should be distinguished from a request to supplement documentation, and the response should follow the competent authority’s notice and the applicable legal provisions.

3. Labeling, Promotion, and Advertising Rules

An advertisement is assessed based on its overall presentation, including names, text, images, symbols, and sound—not its wording alone. False or exaggerated claims and claims of medical efficacy are prohibited. Claims that a cosmetic treats acne, has anti-inflammatory effects, or sterilizes require particular care. The administrative fine is NT$40,000–NT$200,000 for false or exaggerated advertising and NT$600,000–NT$5,000,000 for claims of medical efficacy. Posts by influencers and others should be reviewed under the same standards if they are advertising in substance.

Evaluate the Advertisement as a Whole

Whether labeling, promotion, or advertising is false or exaggerated or claims medical efficacy is not determined by a single word. The product name, sentences, images, symbols, sound, surrounding context, and the overall impression conveyed to consumers are considered together. Because a dominant advertising message is not necessarily cured by a disclaimer in small print, both individual claims and the final advertisement as produced should be reviewed.

For example, saying that a cosmetic treats acne, has an anti-inflammatory effect, or sterilizes may amount to a claim of medical efficacy. The review should also consider claims that associate the product with a disease, before-and-after images, presentations evoking a medical professional, and contexts that connect an ingredient description to a therapeutic effect of the product.

The administrative fine for false or exaggerated advertising is NT$40,000–NT$200,000, while the administrative fine for claims of medical efficacy is NT$600,000–NT$5,000,000. Because the ranges differ by violation type, the advertisement’s overall presentation should be compared against the supporting records before publication.

Influencers, Reviewers, and Sales Partners

A post by an influencer, reviewer, or sales partner may be considered advertising in substance depending on its content and commercial context. Payment, free products, sales links, the brand’s posting instructions, and repeated collaborations are factors that may be considered. Not every personal post automatically becomes brand advertising, however, so the relationship between the poster and the brand, the specific content, and the degree of the brand’s involvement should be examined.

Collaboration agreements and operating guidelines may define the permitted claims and supporting records, pre-publication review, and procedures for correcting or deleting noncompliant claims. Claims added in comments, oral explanations in livestreams or short videos, and inconsistencies among sales pages and labels should also be included within the scope of review. Reviewed drafts, approval history, correction requests, and final published materials should be retained so that the facts can later be verified.

A Pre-Market Compliance Sequence

Reviewing the preparations for sale in Taiwan in the following order can reduce the risk of confusing distinct regulatory systems.

1. Decide whether to establish a Taiwan subsidiary or branch or entrust importation and sales to a local importer.
2. Identify the entity bearing the legal responsibilities of the cosmetics manufacturer or importer and the persons responsible for the contractually allocated tasks.
3. Complete product registration before supplying, selling, giving away, or publicly displaying the product, or providing it to consumers for trial use.
4. Prepare a PIF for each product, update it for changes, and retain it for the statutory period at the required location.
5. Review labels, sales pages, advertising, and collaboration posts based on their overall presentation.
6. Maintain procedures for responding to inspections and corrective requests, complaints and safety information, and any necessary follow-up measures.

For the basic differences between a company and a branch, see Taiwan Company Formation Basics; for the scope of related assistance, see Taiwan Investment and Company Formation Services; and for information about counsel, see Wei Tseng’s Profile.

Official Sources

• Cosmetic Hygiene and Safety Act
• Regulations Governing Notification of Cosmetic Products
• Regulations for Cosmetic Product Information File Management
• TFDA Announcement on the Scope of Cosmetic Product Registration
• TFDA Announcement on Phased PIF Implementation
• TFDA PIF Preparation Guidelines
• TFDA Cosmetics Product Registration Resources
• TFDA Product Information File Resources
• Criteria for Deceptive, Exaggerated, or Medical-Efficacy Claims in Cosmetic Labeling, Promotion, and Advertising
• Official Appendix to the Cosmetics Advertising Criteria
• Ministry of Health and Welfare Announcement on Cosmetics Advertising Regulation
• Invest Taiwan Overview of Foreign Investment
• Department of Investment Review, MOEA

This article provides general educational information about the rules governing entry into Taiwan’s cosmetics market. It is not legal advice on any specific product or advertisement and does not guarantee any permit or registration, eligibility for sale, or processing time. The market-entry structure, product records, labeling and advertising content, and the competent authorities’ current practices should be confirmed for each particular matter.

Wei Tseng (曾雋崴), Taiwan Attorney